A detailed history of Capital International, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Capital International, Inc. holds 109,917 shares of AMGN stock, worth $30.8 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
109,917
Previous 108,764 1.06%
Holding current value
$30.8 Million
Previous $34 Million 4.22%
% of portfolio
0.47%
Previous 0.47%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $356,715 - $388,999
1,153 Added 1.06%
109,917 $35.4 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $2.24 Million - $2.72 Million
8,523 Added 8.5%
108,764 $34 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $27 Million - $32.5 Million
100,241 New
100,241 $28.5 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $1.19 Million - $1.31 Million
-5,420 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $1.15 Million - $1.35 Million
5,420 New
5,420 $1.15 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capital International, Inc. Portfolio

Follow Capital International, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.